Armin Schueler (Armin Schüler)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Network Analysis

Top Venues

Pharmaceutical statistics

CPT: pharmacometrics & systems pharmacology

Biometrical journal. Biometrische Zeitschrift

Journal of biopharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Heiko Götte, Marietta Kirchner, Johannes Krisam, Arthur Allignol, Armin Schueler, Meinhard Kieser
Estimation of treatment effects in early-phase randomized clinical trials involving external control data. Journal of biopharmaceutical statistics (2023)
Heiko Götte, Marietta Kirchner, Johannes Krisam, Arthur Allignol, Francois-Xavier Lamy, Armin Schueler, Meinhard Kieser
An adaptive design for early clinical development including interim decision for single-arm trial with external controls or randomized trial. Pharmaceutical statistics 21 (3) (2022)
Kristyn Pantoja, Shankar Lanke, Alain Munafo, Anja Victor, Christina Habermehl, Armin Schueler, Karthik Venkatakrishnan, Pascal Girard, Kosalaram Goteti
Designing phase I oncology dose escalation using dose-exposure-toxicity models as a complementary approach to model-based dose-toxicity models. CPT: pharmacometrics & systems pharmacology 11 (10) (2022)
Pranab Ghosh, Robin Ristl, Franz Koenig, Martin Posch, Christopher Jennison, Heiko Götte, Armin Schueler, Cyrus R Mehta
Robust group sequential designs for trials with survival endpoints and delayed response. Biometrical journal. Biometrische Zeitschrift 64 (2) (2021)
Celeste Lebbé, Caroline Dutriaux, Thierry Lesimple, Willem Kruit, Joseph Kerger, Luc Thomas, Bernard Guillot, Filippo de Braud, Claus Garbe, Jean-Jacques Grob, Carmen Loquai, Virginia Ferraresi, Caroline Robert, Paul Vasey, Robert Conry, Richard Isaacs, Enrique Espinosa, Armin Schueler, Giorgio Massimini, Brigitte Dréno
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover. Cancers 12 (7) (2020)
Robin Ristl, Nicolás M Ballarini, Heiko Götte, Armin Schueler, Martin Posch, Franz Koenig
Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze RCTs in oncology. Pharmaceutical statistics 20 (1) (2020)